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Abstract
Background: Ardisia crispa Thunb. D.C is used mostly in some parts of the Asian region by traditional practitioners
to treat certain diseases associated with oxidative stress and inflammation including cancer and rheumatism. In
Malaysia, it is popularly known as ‘Mata Ayam’ and local traditional practitioners believed that the root of the plant
is therapeutically beneficial.
Methods: The cytotoxic effect of hydromethanolic extract of A. crispa and its solvents partitions (ethyl acetate and aqueous
extracts) against breast cancer cells were evaluated by using MTT assay. The cells were treated with concentration of extracts
ranging from 15.63 μg/mL- 1000 μg/mL for 72 h. The quantification of phenolic and flavonoid contents of the extracts were
carried out to determine the relationship between of phytochemical compounds responsible for cytotoxic and antioxidative
activities. The antioxidant capacity was measured by DPPH and ABTS free radical scavenging assay and expressed as
milligram (mg) Trolox equivalent antioxidant capacity per 1 g (g) of tested extract.
Results: The hydromethanolic and ethyl acetate extracts showed moderate cytotoxic effect against MCF-7 with IC50 values
of 57.35 ± 19.33 μg/mL, and 54.98 ± 14.10 μg/mL, respectively but aqueous extract was inactive against MCF-7. For MDA-
MB-231, hydromethanolic, ethyl acetate and aqueous extracts exhibited weak cytotoxic effects against MDA-MB-231 with
IC50 values more than 100 μg/mL. The plant revealed high total phenolic content, total flavonoid and antioxidant capacity.
Conclusion: The response of different type of breast cancer cell lines towards A. crispa extract and its partitions varied.
Accordingly, hydromethanolic and ethyl acetate extracts appear to be more cytotoxic to oestrogen receptor (ER) positive
breast cancer than oestrogen receptor (ER) negative breast cancer. However, aqueous extract appears to have poor activity
to both types of breast cancer. Besides that, hydromethanolic and ethyl acetate extracts exhibit higher TPC, TFC and
antioxidant capacity compared to aqueous extract. Synergistic effect of anticancer and antioxidant bioactives compounds of
A. crispa plausibly contributed to the cytotoxic effects of the extract.
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Background
Mammary cancer is a type cancer that arises from the
mammary glands. In humans, it is commonly known as
breast cancer due to the anatomical location at the breast.
In animals, it is still known as mammary cancer. Globally,
breast cancer is the most frequent cancer amongst women
as it accounts for high mortality rate especially in non-
developing countries due to late diagnosis and population
increase. Interestingly, breast cancer also can develop in
males, though relatively very rare (less than 1%) [1] and
the pathophysiology remains uncertain [2, 3].
Since 2003, there have been several new updates of breast
cancer classifications. However, until now, the fundamen-
tals of breast cancer classification are still based on path-
ology and molecular biology [4, 5]. Evidently, pathological
classification is based on characteristics seen under light
microscopy of biopsy specimens. In 2003, the report from
World Health Organization (WHO) stated that there are
20 major tumour types [6]. The debate on the classes of
mammary cancers is still on [6]. However, a majority of the
accepted positions are that most mammary cancers are de-
rived from epithelium lining ducts and lobules [5]. Thus,
these mammary cancers are pathological classified as ductal
or lobular carcinoma [6]. Besides, as part of pathological
classification, the presence of pathological grades such as
the presence of acinar, glandular and pleomorphic in mam-
mary cancers morphology also would be able to determine
the prognosis of the patient [7, 8]. Conversely, the biological
classification is mostly based on endocrinology gene ex-
pression, which are oestrogen receptor (ER) positive/nega-
tive, progesterone receptor (PR)-positive/negative, human
epidermal growth factor (HER2)-positive or HER2-negative
type of mammary cancer [5, 6]. However, there is still space
to study the molecular biology classification of mammary
cancer due to some overlapping amongst immunohisto-
chemistry surrogate and many molecular classes and sub-
types [4]. However, there are two types of breast cancer
cells that have gained interest amongst researchers. They
are the oestrogen receptor (ER) positive breast cancer,
MCF-7 [9] and oestrogen receptor (ER) negative breast
cancer, MDA-MB-231 [10].
Since ancient immemorial times, medicines from herbal
and natural products were widely used in every culture
throughout the world. Medicinal plants generally known
as herbs played significant roles in the development of
drugs and the outcomes have been promising. Therefore,
in the view of exploration for an alternative medicine, par-
ticularly breast cancer studies, local Asian plant named,
Ardisia crispa (Thunb.) A. DC plant was selected due to
evidence that the plant exhibits anti-inflammatory activity
that can be relevant to anti-breast cancer. More so, anti-
inflammation is often associated with inhibition of angio-
genesis [11], which co-jointly regulate the activation of cell
chemotaxis, migration, and proliferation, and thus has the
potential of suppressing tumour growth and metastases.
Hence, the inhibition of angiogenesis is one of the most
promising strategies in the development of novel anti-
cancer therapies, and in the treatment of other human
diseases associated with angiogenesis.
Phytochemical analysis from the leaves extract of A.
crispa showed the presence of many phytochemicals
compound such as flavonoids, phenolics, saponins, tannins,
terpenoids, and steroids [12]. In a previous study by [11], it
was revealed that the root of A. crispa contains various
phytochemical compound such as phenolic, flavonoid and
saponin when hydroethanolic is used as a solvent system.
This plant extract also showed several biological activities
such as anti-inflammatory and anti-hyperalgesic [11, 13],
antipyrexic [14] and antiulcer [15]. Besides that, A. crispa
have been reported to possess cytotoxic effect against hu-
man liver cancer (HepG2), skin cancer cells [16, 17] and
mouse mammary cancer (4 T1) [12]. It is believed that the
plant has anti-inflammatory properties by inhibiting angio-
genesis process. It is also proposed that anti-inflammatory
mechanism could partly involve in the anticancer activity.
Therefore, plants which exert anti-inflammatory activity
will usually exert anticancer activity.
Oxidative stress is one of the pathways of carcinogenesis
and the phenomenon is often associated with inflammatory
cells. The connection between antioxidative and anticancer
activities has been widely subjected to extant empirical en-
deavours. Ardisia crispa is an evergreen flowering plant that
belongs to the family Myrsinaceae. It is widely distributed
over Asian regions including Malaysia. Local Malaysian
people know this plant as ‘pokok mata ayam’ or ‘pokok
mata pelanduk’. Traditionally, the root extract of A. crispa
is believed to be useful in the treatment of several human
ailments such as liver cancer, swelling, rheumatism, cough,
fever, diarrhoea, broken bones, women dysmenorrhoeal,
respiratory tract infections, and traumatic injuries.
Thus far, no empirical submission has been reported on
the cytotoxic and antioxidative properties of any Ardisia
species against breast cancer cell including Ardisia crispa.
This study was conducted with the intention of discover-
ing the true potential of the local herbs for anti-breast
cancer activity which could perhaps reduce the side effects
of current treatment. It could also be used synergistically
with the available one to subsequently improve their
pharmacological and toxicological effect and prognosis of
the treatment. Furthermore, complementary methods
such as using herbs or vitamins to treat cancer or relieve
side effects of cancer is not something new.
Methods
Collection and identification
A. crispa fresh leaves were collected from Biodiversity
Unit, Universiti Putra Malaysia (UPM). The plant samples
were certified by botanist of the Institute Bioscience (IBS),
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UPM, Serdang, Selangor, Malaysia by comparing with a
deposited voucher specimen (SK 2834/15) from Herbar-
ium of Natural Products, IBS, UPM. The appearance of A.
crispa is shown in Fig. 1. The leaves were cleaned and
then dried in oven at 37 °C for a week.
Extraction of plant leaves
The dried leaves of A. crispa were pulverized to become
tiny particles by WARING commercial blender model
HGB2WTS3. Approximately 400 g tiny particles of plant
leaves were soaked in methanol: distilled water (80:20, v/v)
at room temperature for 72 h in a 4000 mL glass conical
flask. The ratio between sample and solvent was 1:20 (w/v).
The mouth of the flasks was wrapped with aluminium foil
to prevent evaporation of the solvent which was under con-
tinues daily shaking for three consecutive days. The mix-
tures were filtrated through cloth filter and cotton wool to
separate solvent-containing extract with the pulverized
leaves and continued filtered with Whatman No. 42 filter
paper to glean cleaned solvent-containing extract. Then,
the pulverized leaves were collected and subjected to simi-
lar extraction process for another two times. The solvent-
containing extract was evaporated under reduced pressure
by using a vacuum rotary evaporator (Heidolph German)
and controlled heating bath at 30 °C. The yield obtained
was kept in oven at 36.5 °C for a week to remove methanol
residue, then the crude extract was further purified with
ethyl acetate and aqueous by using solvent partitioning
techniques with modifications [18]. Two solvents (ethyl
acetate and aqueous) with difference polarity were chosen
to see the impact of different partitioned solvents on chem-
ical composition and bioavailability of the A. crispa, since
ethyl acetate is a less polar solvent and aqueous is a polar
solvent. Two gram of crude hydromethanolic extract of A.
crispa (HEAC) was soaked in 100 mL methanol, then
placed in sonicator and gently mixed to dissolve the sample
properly. Two hundred millilitres of sterile distilled water
was added to the mixture to make a suspension. The sus-
pension form was subjected to partition with 700 mL ethyl
acetate. The two separate layers were formed and ethyl
acetate and aqueous fractions were filtered and collected.
The procedure was repeated twice. Then, ethyl acetate frac-
tion was evaporated under reduced pressure by using a vac-
uum rotary evaporator (Heidolph German) and controlled
heating bath at 30 °C. The aqueous fraction was filtered
and the solution was subjected to the freeze-drying process
for 4 days. The yields that obtained were stored at − 20 °C
until used for analysis.
Cell preparation and maintenance
The MCF-7, and MDA-MB-231 cancer cell lines were
grown in RPMI 1640 media with L-glutamine, supple-
mented with 10% foetal bovine serum (FBS) (Gibco, 1%
antibiotic-antimycotic (10,000 units/mL of penicillin,
10,000 μg/mL of streptomycin and 25 μg/mL amphotericin
B) as a complete growth medium (CGM). All consumable
materials were purchased from Gibco Thermo Fisher Sci-
entific, USA. The cells were thawed gradually from liquid
nitrogen to − 80 °C and then 36.5 °C water bath prior to
culture. One millilitre of cells was transferred to 15 mL
centrifuge tube and 3 mL of complete growth medium was
added and centrifuged at 1200 rpm for 5 min. The super-
natant was removed and pellets were re-suspended with
1 mL of complete growth medium. The 1 mL of cells sus-
pension then was transferred to 75 cm2 cell culture flask.
Ten mL of complete growth media was added to the flask
carefully and flask was incubated at 37 °C with 5% CO2 in
incubator. Cultured flasks were subcultured into another
Fig. 1 Ardisia crispa Thunb. D.C. Photo was captured at the Agricultural Conservatory Park, Institute of Bioscience, Universiti Putra Malaysia. a plant
b leaves
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flask once the cells reach 80% confluency. The cells were
detached with 1.5 mL of 0.25% trypsin-EDTA after removal
of old media and washed with 5 mL PBS. Cells were
checked microscopically daily to ensure the cells are in
healthy condition.
Microculture tetrazolium (MTT) assay
Cytotoxicity assay was prepared with seeding density of
1x105cells/mL of complete growth medium in sterile 96-
well flat bottom culture plates. Each well was filled with
100 μl of cells suspension (MCF 7, and MDA-MB-231).
This was followed by incubation of plates at 37 °C with 5%
CO2 overnight to allow cells attachment. Serially diluted
hydromethanolic extract of A. crispa (HEAC), ethyl acetate
extract of A. crispa (EAEAC), aqueous extract of A. crispa
(AQEAC) with concentrations ranging from 15.63 μg/mL,
31.25 μg/mL, 62.5 μg/mL, 125 μg/mL, 250 μg/mL, 500 μg/
mL and 1000 μg/mL, were added into the appropriate wells
in four replicates for each concentration. Untreated cells
(0 μg/mL) was used as control. Each concentration of
treated cells, untreated cells and blank was performed in
triplicate in one plate and the experiment was repeated for
three times for validity. Seventy two hours treatment time
was chosen which is in line with a number of previous ex-
periment, that the treatment effect was to be done in a time
dependent manner [19–21]. Therefore, following a 72-h in-
cubation period at 37 °C with 5% CO2 in incubator, 20 μl of
MTT solution was added to wells and incubated for an
additional 4 h. Medium of each well was carefully aspirated
without disturbing MTT crystal in each well. One hundred
microliters of DMSO solution was added into each well to
dissolve the purple formazan crystals. The optical density
(OD) of formazan was proportional to the number of sur-
vival cells that metabolically active, and was read at 570 nm
wavelength [22] using spectrophotometry (Infinite M200
PRO). The experiment was repeated thrice. After 4-h incu-
bation period for formazan formation, the optical densities
(OD) values, dose-response curves (percentage of cell sur-
vivability vs concentration) were generated using linear re-
gression interpolation analysis to obtain IC50 (minimum
concentration of hydromethanolic extract that giving 50%
survival of MCF-7, and MDA-MB-231 cells). The histo-
gram for cell survivability was constructed by using Graph-
Pad Prism Software 5.0.
Percent of cell survivability was calculated according
to the following equation:-
Cell survivability %ð Þ ¼ mean OD of treated cell−mean OD of blank
mean OD of untreated cell−mean OD of blank
 100%
[23]
The cytotoxic effect against cancer cell was recorded
as IC50 and compared with untreated cells [12, 20, 24].
The percentage of cell survivability values against
concentration of respective extracts were plotted in
order to determine the IC50 values of each extract.
Determination of phytochemical constituents
Total phenolic content
Quantitative assessment of total phenolic content (TPC) was
conducted according to the method described by [25, 26] by
using 5 mL Folin-Ciocalteu chemical reagent diluted with
45 mL to form Folin-Ciocalteu solution. Then, 1.0 mg
hydromethanolic extract of A. crispa (HEAC), ethyl acetate
extract of A. crispa (EAEAC) and aquoues extract of A.
crispa (AQEAC) were dissolved in 99.9% assay percent range
of methanol, purchased from Fisher Scientific, USA. Each
100 μL of extract solution, control solution (methanol) and
standard (gallic acid) were mixed with 400 μL of 7.5% so-
dium bicarbonate (NAHCO3) and 500 μL Folic-Ciocalteu so-
lutions. The mixture was incubated for 2 h in the dark room
at 40 °C. All the tested samples (200 μL) were pipetted into
96 well ELISA plate readers. Optical density (OD) was deter-
mined at 760 nm. Gallic acid calibration curve was generated
from the gallic acid – Folin reaction ranging from 100 μg/
mL, 50 μg/mL, 25 μg/mL, 12.5 μg/mL, 6.25 μg/mL, and
3.13 μg/mL. The results were expressed as milligram (mg)
gallic acid per one gram extract (mg GAE/g extract).
Total flavonoid content
Quantitative assessment of total flavonoid content (TFC) was
conducted in line with the method described by [25, 26]. Ba-
sically, 150 μL from (1 mg/mL methanol) of HEAC, EAEAC
and AQEAC was mixed with 150 μL 10% aluminium chlor-
ide (AlCl3) solution and incubated for 10 min at dark room.
Meanwhile, 150 μL methanol was used as negative control
and 150 μL of rutin (100 μg/mL, 50 μg/mL, 25 μg/mL,
12.5 μg/mL, 6.25 μg/mL, 3.13 μg/mL) were used as standard.
Both are mixed with 150 μL of 10% AlCl3 and incubated
similar to the extracts. Three hundred microliter of each ex-
tract, negative control and standard mixtures were pipetted
out into 96 well plates and analyzed under spectrophotom-
eter at 435 nm. Rutin calibration curve was generated from
the optical density of rutin – AlCl3 reaction ranging from
100 μg/mL, 50 μg/mL, 25 μg/mL, 12.5 μg/mL, 6.25 μg/mL,
and 3.13 μg/mL. The results were expressed as milligram
(mg) rutin per one gram extract (mg RE/g extract).
Antioxidant assays
DPPH free radicals scavenging assay Antioxidant test
by using DPPH (1,1-diphenyl-1-picrylhydrazyl) compound
was conducted according to the method described by [27].
Four point two milligram of DPPH compound was diluted
with 50 mL of methanol to make a DPPH solution then, the
chemical was incubated for 2 h. One milligram of trolox was
dissolved into one milliliter of methanol as a stock solution.
Trolox (6-hydroxyl-2,5,7,8-tetramethyichroman-2-carboxylic
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acid, 97% purity) was used as reference (standard). Then,
one hundred microliter of trolox solution was serially diluted
into final concentrations which were 50 μg/mL, 25 μg/mL,
12.5 μg/mL, 6.25 μg/mL, and 3.13 μg/mL. Methanol served
as negative control while distilled water is the blank. Each of
the negative control and standard were mixed with 585 μL
DPPH solution in 2 mL vial and wrapped with aluminum
foil. The tested samples were incubated in the dark room for
one hour.
The tested samples were analyzed simultaneously by
using spectrophotometer at 515 nm wavelength and per-
formed triplicate (n = 3) for effectual reproducibility. Effect-
ive concentration of trolox that providing 50% antioxidant
capacity (EC50) was calculated according to the formula
stated below to obtained trolox calibration curve:
Scavenging activities %ð Þ : Ac−Asð Þ= Acð Þ  100%
where:
Ac: Absorbance of control.
As: Absorbance of sample.
The antioxidant capacity of HEAC, EAEAC, and AQEAC
against the DPPH solution then was estimated through
Trolox calibration curve. The results were expressed as
milligram Trolox equivalent antioxidant capacity (TEAC)
per one gram of tested extract.
ABTS free radical scavenging assay Antioxidant test
using ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) compound was conducted according to
the method described by [27]. ABTS stock solution was
prepared by mixing 2.45 mM potassium persulphate
(K2S2O8) solution with 38.4 mg/mL ABTS in a volumet-
ric flask and incubated for 16 h in dark room. The mix-
ture then was continually diluted with double distilled
water and monitored spectrophotometrically at 735 nm
until the absorbance value was at 0.7.
Trolox (1mg/mL) was prepared as a stock solution. Then,
one hundred microliter of Trolox solution was serially di-
luted into final concentrations which were 100 μg/mL,
50 μg/mL, 25 μg/mL, 12.5 μg/mL, 6.25 μg/mL, and
3.13 μg/mL. While trolox solution acted as a reference for
antioxidant capacity, methanol served as a negative control
with distilled water being the blank. Each of negative con-
trol and standard were mixed with 2.85 mL ABTS solution
in 15 mL centrifuge tube and wrapped with aluminum foil
to prevent light penetration. The mixtures were incubated
in the dark room for one hour and organized into 96 well
plates. Each concentration was performed in triplicate (n =
3) for effectual reproducibility. The plate was analyzed by
using spectrophotometer at 734 nm wavelength. In order
to obtain trolox calibration curve, effective concentration of
trolox that providing 50% antioxidant capacity (EC50) was
calculated according to the formula stated below:
Scavenging activities %ð Þ : Ac−Asð Þ= Acð Þ½   100%
where:
Ac: Absorbance of control.
As: Absorbance of sample.
The antioxidant capacity of HEAC, EAEAC, and
AQEAC against ABTS free radical solution then, was es-
timated through Trolox calibration curve. The results
were expressed as milligram trolox equivalent antioxi-
dant capacity (TEAC) per one gram of tested extract.
Statistical analysis
All the percentages of cell survivability were expressed as
mean (n = 3) per plate ± SD (Standard deviation) and
differences among treated and untreated cells were
analysed using one way ANOVA followed Dunnett’s mul-
tiple comparison test. The test was considered statistically
significant when P < 0.05 as compared to untreated cell
(control) and GraphPad Prism Software 5.0 was used to
analyse all statistical tests.
Data were expressed as mean of three times experiment
(n = 3) ± SD (standard deviation) and the difference of
TPC and TFC among sample extracts were determined
using one way analysis of variance (ANOVA) followed by
Tukey’s multiple comparison test. The statistical analysis
test was performed using GraphPad Prism Software 5.0.
The sample was differred significantly when (P < 0.05).
Results
Effect of HEAC, EAEAC, and AQEAC on MCF-7 and MDA-MB-
231 breast cancer
Figures 2 and 3 show the cell survivability (%) of MCF-7
and MDA-MB-231 breast cancer cell line following
treatment with HEAC, EAEAC and AQEAC extracts for
72 h, respectively. The IC50 values of HEAC, EAEAC
and AQEAC were shown in Table 1. In general, AQEAC
showed a poor cytotoxic effect on breast cancer cell lines
with IC50 values more than 300 μg/mL on both breast
cancer cell lines (Table 1).
Quantitative determination of total phenolic contents (TPC)
The results of total phenolic content from HEAC, EAEAC
and AQEAC were shown in Fig. 4 ranging from 120.32 to
419.92 mg GAE/g extract. Overall, A. crispa contain very
high amount of phenolic compound. Based on standard a
TPC value higher than 10 mg GAE/g extract was considered
high [28]. However, amongst EAEAC extract has the highest
amount of total phenolic content followed with HEAC and
AQEAC (Fig. 4). The TPC values was obtained from gallic
acid calibration curve (y = 0.002× – 0.0004; R2 = 0.999).
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Quantitative determination of total flavonoid contents (TFC)
The flavonoid content of HEAC, EAEAC and AQEAC
were expressed as rutin equivalents (RE). From the results
shown in Fig. 5, A. crispa contain very high amount of fla-
vonoid in EAEAC and followed by HEAC and AQEAC.
TFC was considered high when its amount more 10 mg
RE/g extract. The TFC values were obtained from rutin
calibration curve (y = 0.0117× + 0.0177; R2 = 0.9989).
Antioxidant capacities
Antioxidant capacities of hydromethanolic extract of A.
crispa and its partitions, namely EAEAC and AQEAC
were assessed by 2 types of antioxidant tests, including
DPPH and ABTS assays. The total content of phenolic
and it derivatives, flavonoid from all HEAC, EAEAC and
AQEAC were also been evaluated to link the relationship.
The DPPH and ABTS radicals scavenging activities
were estimated through Trolox calibration curve (y =
1.0429×-0.2747; R2 = 0.9999) and (y = 0.5167×-0.3429;
R2 = 0.9996), respectively. The tested extracts were per-
formed in triplicate (n = 3) and was expressed as milli-
gram (mg) Trolox equivalent antioxidant capacity
(TEAC) per 1 g (g) of tested extract (Table 2 and
Table 3). Overall, antioxidant capacity of A. crispa was
considered high. HEAC, EAEAC and AQEAC showed
good scavenging activities, able to scavenge at least 50%
of free radicals solution below than 10 mg/mL of extract
concentration.


































Fig. 2 Cell survivability (%) of MCF-7 breast cancer cell line following treatment with HEAC, EAEAC and AQEAC extracts for 72 h. All values are
expressed as mean (n = 3) ± SD for triplicate. The comparison between treated cells and untreated cells was evaluated using one way ANOVA
followed by Dunnett’s multiple comparison test. * P < 0.05, and *** P < 0.001 denote significant difference as compared to untreated cell (control)
































Fig. 3 Cell survivability (%) of MDA-MB-231 breast cancer cell line following treatment with HEAC, EAEAC, AQEAC extracts for 72 h. All values are
expressed as mean (n = 3) ± SD for triplicate. The comparison between treated cells and untreated cells was evaluated using one way ANOVA
followed by Dunnett’s multiple comparison test. **P < 0.01, denote significant difference as compared to untreated cell (control)
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Discussion
The cytotoxic effect of HEAC and its partitions were
assessed based on the minimum concentration of extract
that giving at least 50% of the cancer cell survivability
(IC50). The four categories of extracts which are; very active
(IC50 ≤ 20 μg/mL), moderately active (IC50 > 20–100 μg/
mL), weakly active (IC50 > 100–1000 μg/mL) and inactive
(IC50 > 1000 μg/mL), [23, 29]. For pure compound or drug,
IC50 value less than 4 μg/mL is considered potent [30, 31].
Cytotoxic analysis revealed that, HEAC and EAEAC pos-
sessed moderate cytotoxic effect against MCF-7 with IC50
57.35 ± 19.33 μg/mL and 54.98 ± 14.10 μg/mL, respectively.
HEAC and EAEAC showed weak cytotoxic effect (IC50 >
100–1000 μg/mL) on MDA-MB-231. For AQEAC, the
IC50 value against MCF-7 was more than 1000 μg/mL and
MDA-MB-231 was 347.44 ± 98.78 μg/mL indicating that
AQEAC has poor cytotoxic effect against breast cancer. In
this study, it showed the response of breast cancer cell lines
toward A. crispa extract and its partitions was variable. It is
in agreement with previous studies that the response to-
wards each breast cancer was difference depending on the
classification and degree of malignancy of cancer cells [32].
Moreover, differences in cell line, plant extract, solvent
used, and plant source also contribute to the difference
cytotoxic effect possessed by the plant [33]. However, from
the results, it might suggest that oestrogen receptor (ER)
positive breast cancer susceptible to hydromethanolic and
ethyl acetate extracts of A. crispa.




IC50 values of extracts/drug (μg/mL)
HEAC EAEAC AQEAC
MCF-7 57.35 ± 19.33 54.98 ± 14.10 > 1000






























Fig. 4 Total phenolic content of the HEAC is 156.30 ± 2.00, EAEAC is
419.92 ± 18.76 and AQEAC is 120.32 ± 9.54 mg GAE/g extract,
respectively. Data for total phenolic content are expressed in means
(three replicates) ± SD. Means with different letter within the same
column differ significantly (P< 0.05) according to one way ANOVA






























Fig. 5 Total flavonoid content of the HEAC is 45.93 ± 0.94, EAEAC is
183.62 ± 13.10 and AQEAC is 18.32 ± 0.94 mg RE/g extract,
respectively. Data for total flavonoid content are expressed in means
(three replicates) ± SD. Means with different letter within the same
column differ significantly (P < 0.05) according to one way ANOVA
following Tukey’s multiple comparison test
Table 2 DPPH scavenging assay of A. crispa leaves from
different solvent extracts
Extract Antioxidant capacity (mg TEAC/g extract)
HEAC 175.64 ± 2.89
EAEAC 416.28 ± 2.46
AQEAC 89.24 ± 1.67
The tested extract were performed triplicate (n = 3) and was expressed as
milligram (mg) Trolox equivalent antioxidant capacity (TEAC) per 1 g (g) of
tested extract
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Overall, A. crispa plant had high TP, TFC values and anti-
oxidant capacity. However, amongst extracts, EAEAC had
the highest level of TPC, TFC and antioxidative activities
followed by HEAC and AQEAC. HEAC and EAEAC re-
vealed more total phenolic and flavonoid contents as com-
pared to aqueous extract (AQEAC). This result explained
the weak cytotoxicity effect exhibited by AQEAC as the
phytochemical compounds contribute significantly in the
ethnopharmacological medicinal values of the plants.
It is also revealed from the analysis conducted that
EAEAC possessed the highest scavenging activities as high
antioxidative activities were contributed by the highest level
of TPC and TFC values of the extarct. Ethyl acetate might
be the good solvent for extracting phytochemical com-
pounds with antioxidant properties. This is similar to previ-
ous studies conducted by [34], that TPC of ethyl acetate
(EA) extract of Alpinia mutica (1.55 ± 0.16 mg GAE/g ex-
tract) was the highest when compared to its crude hydro-
methanolic, hexane and aqueous extract. The results from
the same study also revealed that EA of Alpinia mutica
possessed the highest antioxidant capacity (EC50: 0.125 ±
0.04 μg/mL) which correlates with its TPC finding. TPC
was considered high when TPC level higher than 10 mg
GAE/g extract [28]. The level of TFC and TPC are the
same in descending order; EAEAC > HEAC > AQEAC be-
cause flavonoid is a subgroup of phenolics compound.
For antioxidant capacity determination, A. crispa pos-
sess high antioxidant capacity which is good to scavenge
free radical in the body. The benchmark for the plant was
considered high TPC and TFC values 10 mg GAE/g ex-
tract and 10 mg RE/ g extract, respectively, while for
DPPH and ABTS scavenging assays were EC50 < 10 mg/
mL [26, 35]. EAEAC contains highest TPC and TFC
followed with HEAC and AQEAC. The findings of DPPH
and ABTS scavenging assays also showed that Ardisia
crispa leaves extract possess high antioxidant capacity and
the results were in agreement with TPC and TFC findings.
EAEAC has the highest scavenging activity followed by
HEAC and AQEAC. These results in agreement with
many previous studies who found that the level of TPC
and TFC in extract play a major role for antioxidant cap-
acity [36–39]. The difference of antioxidant capacities
among HEAC, EAEAC and AQEAC was due to the solv-
ent used during partitioning. The change in location of
hydroxyl group attached to aromatic ring in phenolics
compound and benzene ring of flavonoids specifically
affect the antioxidant properties [40, 41].
Notwithstanding that the EAEAC exhibit the highest an-
tioxidative activity, it is not a potent cytotoxic plant. This is
because, not necessarily phenolic and flavonoid compounds
are responsible for anticancer properties. The phytochem-
ical compound of plants are of multicomponent mixture.
Other phytochemical constituents such as saponins also ex-
hibit anticancer properties [42, 43]. Besides, phenolic has
broad secondary plant metabolites and many subgroup/
class. Moreover, it can presence with combination of other
compounds such as terpenoids, saponins, glycosides,
chlorophyl, lipid, protein, polysaccharides and cyanides
[44]. For example, terpenoids and saponins are phytochem-
ical compounds that have anticancer effect [45–47]. Hence,
it is plausible that during partitioning of HEAC with ethyl
acetate and aqueous solvent, the chemical characteristic or
solubility of some phytochemical composition was altered,
thus making it toxic or less potent. Since, phytochemical
compound is a complex multicomponent form, separation
of the compounds possibly alter the action of mixture
compound, resulting in the loss of synergestic effect of the
extract. Higher phenolic and flavonoid compounds in
EAEAC as compared to HEAC and AQEAC, could be due
to some phenolic subgroup/subclass reacts strongly with
the Folin–Ciocalteu reagent [48, 49]. Therefore, the use of
solvent partitioning method might contribute to structural
alteration effect of the phytochemical compounds and
affect the therapeutic value. Based on reference value and
other studies, HEAC is considered among extracts that
have good scavenging activitiy. Futhermore, HEAC is in the
same category of cytotoxic effect as EAEAC against MCF-7
and MDA-MB-231. The only criteria that need to be con-
sidered to choose among HEAC and EAEAC is the safetly
level. Extracts with good scavenging activities might be
beneficial in complimentary with chemotherapeutic drugs
in order to minimizing the side effects from the chemother-
apeutic agent. In addition, it can perhaps prevent the car-
cinogenesis pathway.
Conclusion
Based on results, hydromethanolic and ethyl acetate
extracts of Ardisia crispa can be a potential candidate
for oestrogen receptor (ER) positive breast cancer agent
because it is more cytotoxic to MCF-7 cancer cell lines
as compared to MDA-MB-231. Thus, the extracts are
believed to exert good scavenging activities via phenolic
and flavonoid compounds. All these findings indicate the
need for new investigations with blocker of oestrogen
receptor (ER) with the aim to strictly define the anti-
oestrogenic effect of Ardisia crispa extracts on ER posi-
tive cancer cells. The successful results of this, an
additional set of investigations, after in vivo studies,
Table 3 ABTS scavenging assay of A.crispa leaves from different
solvent extracts
Extract Antioxidant capacity (mg TEAC/g extract)
HEAC 294.62 ± 10.14
EAEAC 1228.68 ± 65.19
AQEAC 186.02 ± 3.83
The tested extract were performed triplicate (n = 3) and was expressed as
milligram (mg) Trolox equivalent antioxidant capacity (TEAC) per 1 g (g) of
tested extract
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could help to understand is it possible to combine the
most powerful extracts with the available drug and to
encounter drug resistance and adverse effects.
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